DNAJC5 and malaria: Finally, our study further provides a rational basis for the evaluation of CyRPA based multiantigen combinations targeting different erythrocyte invasion ligands (RH5, Ripr) and steps (MSP-119) as well as multiple parasite stages (CSP, Pfs230) with novel human adjuvants in order to meet the challenges in malaria vaccine development efforts.